Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands

Fig. 2

Incremental cost-effectiveness plane for procalcitonin (PCT) guidance compared with standard of care for costs until one year after ICU admission. This incremental cost-effectiveness plane shows the impact of the use of a PCT-guided antibiotic treatment algorithm, as compared to standard of care, on the difference in quality-adjusted life years (QALYs) (until one year after ICU admission) and accompanying healthcare-related costs within this one-year time period. In addition, the willingness-to-pay (WTP) thresholds of €20,000/QALY and €80,000/QALY are shown. The result is based on 10,000 bootstrap samples

Back to article page

Critical Care

ISSN: 1364-8535